These findings provide a new perspective on the dualistic nature of IGF2BP1 in cancer biology and highlight the relevance of caspase-3 as a downstream effector potentially mitigating the oncogenic effects of RNA-binding proteins. This evidence concerns the gene CASP3 and cancer.